Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus

10.1055/a-2311-9952

Aktualisierungshinweis

Die DDG-Praxisempfehlungen werden regelmäßig zur zweiten Jahreshälfte aktualisiert. Bitte stellen Sie sicher, dass Sie jeweils die neueste Version lesen und zitieren.

Publication History

Received: 26 June 2025

Accepted: 09 October 2025

Article published online:
24 December 2025

• Literatur

• 1 Beck J, Greenwood DA, Blanton L. et al. 2017 National Standards for Diabetes Self-Management Education and Support. Diabetes Educ 2020; 46: 46-61
• 2 Beck J, Greenwood DA, Blanton L. et al. 2017 National Standards for Diabetes Self-Management Education and Support. Diabetes Care 2017; 40: 1409-1419
• 3 Evert AB, Dennison M, Gardner CD. et al. Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Diabetes Care 2019; 42: 731-754
• 4 Ausschuss Ernährung der Deutschen Diabetes Gesellschaft. Stellungnahme des Ausschuss Ernährung der DDG zum Consensus Report: Nutrition Therapy for Adults with Diabetes or Prediabetes. Accessed June 12, 2023 at: https://www.deutsche-diabetes-gesellschaft.de/fileadmin/user_upload/06_Gesundheitspolitik/01_Stellungnahmen/2019/20190927_Ausschuss_Ernaehrung_DDG_Stellungnahme_zu_den_ADA_Ernaehrungsempfehlungen.pdf
• 5 American Diabetes Association. 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2020. Diabetes Care 2020; 43: S48-S65
• 6 Dyson PA, Twenefour D, Breen C. et al. Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes. Diabet Med 2018; 35: 541-547
• 7 Dworatzek PD, Arcudi K, Gougeon R. et al. Nutrition therapy. Can J Diabetes 2013; 37 (Suppl. 01) S45-S55
• 8 Kröger J, Siegmund T, Schubert-Olesen O. et al. AGP-Fibel Ernährung. Mit CGM postprandiale Glukoseverläufe analysieren. Mainz: Kirchheim + Co; 2020
• 9 Deutsche Diabetes Gesellschaft (DDG). Therapie des Typ-1-Diabetes. S3-Leitlinie. Version 5.0 – September 2023. AWMF-Registernr. 057–013. https://register.awmf.org/de/leitlinien/detail/057–013
• 10 Scavone G, Manto A, Pitocco D. et al. Effect of Carbohydrate Counting and Medical Nutritional Therapy on Glycaemic Control in Type 1 Diabetic Subjects: A Pilot Study. Diabet Med 2010; 27: 477-479
• 11 Smart CE, King BR, McElduff P. et al. In children using intensive insulin therapy, a 20 g variation in carbohydrate amount signigicantly impacts on postprandial glycaemia. Diabet Med 2012; 29: e21-e24
• 12 Bell KJ, King BR, Shafat A. et al. The Relationship Between Carbohydrate and the Mealtime Insulin Dose in Type 1 Diabetes. J Diabetes Complicat 2015; 29: 1323-1329
• 13 Smart CE, Ross K. et al. Can children with Type 1 diabetes and their caregivers estimate the carbohydrate conent of meals and snacks. Diabet Med 2010; 27: 348-353
• 14 Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: 2008. Diabetes Care 2008; 31: 2281-2283
• 15 Chantelau EA. Quantifizierung des Blutglukoseeffekts der Nahrungsmittel: der glykämische Index. In: Berger M. , Hrsg. Diabetes mellitus. München Jena: Urban & Fischer; 2000: 158-163
• 16 Strohm D. Glykämischer Index und glykämische Last – ein für die Ernährungspraxis des Gesunden relevantes Konzept? Wissenschaftliche Stellungnahme der DGE. Ernährungs Umschau 2013; 60: M26-M38
• 17 Chantelau E, Kronsbein P, Kempf U. et al. Untersuchung zum mahlzeitenbezogenen Insulinbedarf von Linsen und Kartoffeln bei Patienten mit Typ-I-Diabetes mellitus. Aktuelle Ernährungsmedizin 1989; 14: 175-178
• 18 Lafrance L, Rabasa-Lhoret R, Poisson D. et al. Effects of different glycaemic index foods and dietary fibre intake on glycaemic control in type 1 diabetic patients on intensive insulin therapy. Diabet Med 1998; 15: 972-978
• 19 Parillo M, Annuzzi G, Rivellese AA. et al. Effects of meals with different glycaemic index on postprandial blood glucose response in patients with Type 1 diabetes treated with continuous subcutaneous insulin infusion. Diabet Med 2011; 28: 227-229
• 20 Fontvieille AM, Acosta M, Rizkalla SW. et al. A moderate switch from high to low glycaemic-index foods for 3 weeks improves the metabolic control of Type I (IDDM) diabetic subjects. Diabetes Nutr Metab 1988; 1: 139-143
• 21 Thomas DE, Elliott EJ. The use of low-glycaemic index diets in diabetes control. Br J Nutr 2010; 104: 797-802
• 22 Giacco R, Parillo M, Rivellese AA. et al. Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care 2000; 23: 1461-1466
• 23 Fontvieille AM, Rizkalla SW, Penfornis A. et al. The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks. Diabet Med 1992; 9: 444-450
• 24 Vega-López S, Venn BJ, Slavin JL. Relevance of the Glycemic Index and Glycemic Load for Body Weight, Diabetes, and Cardiovascular Disease. Nutrients 2018; 10: 1361
• 25 Nansel TR, Gellar L, McGill A. Effect of varying glycemic index meals on blood glucose control assessed with continuous glucose monitoring in youth with type 1 diabetes on basal-bolus insulin regimens. Diabetes Care 2008; 31: 695-697
• 26 Ryan RL, King BR, Anderson DG. et al. Influence of and optimal insulin therapy for a low-glycemic index meal in children with type 1 diabetes receiving intensive insulin therapy. Diabetes Care 2008; 31: 1485-1490
• 27 Collier GR, Giudici S, Kalmusky J. et al. Low glycaemic index starchy foods improve glucose control and lower serum cholesterol in diabetic children. Diabetes Nutr Metab 1988; 1: 11-19
• 28 Gilbertson HR, Brand-Miller JC, Thorburn AW. et al. The effect of flexible low glycemic index dietary advice versus measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes. Diabetes Care 2001; 24: 1137-1143
• 29 Pańkowska E, Błazik M, Groele L. Does the fat-protein meal increase postprandial glucose level in type 1 diabetes patients on insulin pump: the conclusion of a randomized study. Diabetes Technol Ther 2012; 14: 16-22
• 30 Winiger G, Keller U, Laager R. et al. Protein content of the evening meal and nocturnal plasma glucose regulation in type-I diabetic subjects. Horm Res 1995; 44: 101-104
• 31 Smart CEM, Evans M, O’Connell SM. et al. Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive. Diabetes Care 2013; 36: 3897-3902
• 32 Pańkowska E, Błazik M. Bolus calculator with nutrition database software, a new concept of prandial insulin programming for pump users. J Diabetes Sci Technol 2010; 4: 571-576
• 33 Herman K. et al. Untersuchungen zur Effektivität und Sicherheit einer zusätzlichen Insulingabe für Mahlzeiten mit hohem Fett- und Eiweißgehalt bei Patienten mit Typ-1-Diabetes mellitus. Im Rahmen einer Promotionsarbeit. 2019
• 34 Eschenburger S, Tombek A. et al. Untersuchung einer Nussmahlzeit als Spätmahlzeit unter Berücksichtigung einer kontinuierlichen Glucosemessung. Im Rahmen einer Masterarbeit 2020 (nicht veröffentlicht).
• 35 Krems C, Walter C, Heuer T. et al. Nationale Verzehrsstudie II – Lebensmittelverzehr und Nährstoffzufuhr auf Basis von 24h-Recalls. Max Rubner-Institut. Accessed June 12, 2023 at: https://www.mri.bund.de/fileadmin/MRI/Institute/EV/Lebensmittelverzehr_N%C3%A4hrstoffzufuhr_24h-recalls-neu.pdf
• 36 Mottalib A, Kasetty M, Mar JY. et al. Weight Management in Patients with Type 1 Diabetes and Obesity. Curr Diab Rep 2017; 17: 92
• 37 Basu A, Alman AC, Snell-Bergeon JK. Dietary fiber intake and glycemic control: coronary artery calcification in type 1 diabetes (CACTI) study. Nutr J 2019; 18: 23
• 38 Franz MJ, Powers MA, Leontos C. et al. The Evidence for Medical Nutrition Therapy for Type 1 and Type 2 Diabetes in Adults. J Am Diet Assoc 2010; 110: 1852-1889
• 39 Toews I, Lohner S, Küllenberg de Gaudry D. et al. Association between intake of non-sugar sweeteners and health outcomes: systematic review and meta-analyses of randomised and non-randomised controlled trials and observational studies. BMJ 2019; 364: k4718
• 40 Hunter SR, Reister EJ, Cheon E. et al. Low Calorie Sweeteners Differ in Their Physiological Effects in Humans. Nutrients 2019; 11: 2717
• 41 European Food Safety Authority (EFSA) schließt vollständige Risikobewertung zu Aspartam ab und kommt zu dem Schluss, dass es in den derzeitigen Expositionsmengen sicher ist, 10.12.2013. Accessed August 02, 2020 at: https://www.efsa.europa.eu/de/press/news/131210
• 42 Sylvetsky AC, Rother KI. Nonnutritive Sweeteners in Weight Management and Chronic Disease: A Review. Obesity (Silver Spring) 2018; 26: 635-640
• 43 Ashwell M, Gibson S, Bellisle F. et al. Expert consensus on low-calorie sweeteners: facts, research gaps and suggested actions. Nutr Res Rev 2020; 33: 1-10
• 44 Romo-Romo A, Aguilar-Salinas CA, Brito-Córdova GX. et al. Effects of the Non-Nutritive Sweeteners on Glucose Metabolism and Appetite Regulating Hormones: Systematic Review of Observational Prospective Studies and Clinical Trials. PLoS One 2016; 11: e0161264
• 45 Rogers PJ, Hogenkamp PS, de Graaf C. et al. Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies. Int J Obes (Lond) 2016; 40: 381-394
• 46 Fantino M, Fantino A, Matray M. et al. Beverages containing low energy sweeteners do not differ from water in their effects on appetite, energy intake and food choices in healthy, non-obese French adults. Appetite 2018; 125: 557-565
• 47 Bellisle F. Intense Sweeteners, Appetite for the Sweet Taste, and Relationship to Weight Management. Curr Obes Rep 2015; 4: 106-110
• 48 Ahmad SY, Azad MB, Friel J. et al. Recent evidence for the effects of nonnutritive sweeteners on glycaemic control. Curr Opin Clin Nutr Metab Care 2019; 22: 278-283
• 49 S3-Leitlinie Therapie des Typ-1-Diabetes, 2. Auflage. Accessed June 12, 2023 at: https://www.awmf.org/uploads/tx_szleitlinien/057–013l_S3-Therapie-Typ-1-Diabetes_2018–08.pdf
• 50 Nansel TR, Lipsky LM, Liu A. Greater diet quality is associated with more optimal glycemic control in a longitudinal study of youth with type 1 diabetes. Am J Clin Nutr 2016; 104: 81-87
• 51 Nezu U, Kamiyama H, Kondo Y. et al. Effect of low-protein diet on kidney function in diabetic nephropathy: meta-analysis of randomised controlled trials. BMJ Open 2013; 3: e002934
• 52 Dussol B, Iovanna C, Raccah D. et al. A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy. J Ren Nutr 2005; 15: 398-406
• 53 Seckold R, Fisher E, de Bock M. et al. The ups and downs of low-carbohydrate diets in the management of Type 1 diabetes: a review of clinical outcomes. Diabet Med 2019; 36: 326-334
• 54 Donaghue KC, Pena MM, Chan AKF. et al. Beneficial effects of increasing monounsaturated fat intake in adolescents with type 1 diabetes. Diabetes Res Clin Pract 2000; 48: 193-199
• 55 Cadario F, Prodam F, Pasqualicchio S. et al. Lipid profile and nutritional intake in children and adolescents with Type 1 diabetes improve after a structured dietician training to a Mediterranean-style diet. J Endocrinol Invest 2012; 35: 160-168
• 56 Zhong VW, Lamichhane AP, Crandell JL. et al. Association of adherence to a Mediterranean diet with glycemic control and cardiovascular risk factors in youth with type I diabetes: the SEARCH Nutrition Ancillary Study. Eur J Clin Nutr 2016; 70: 802-807
• 57 Peairs AD, Shah AS, Summer S. et al. Effects of the dietary approaches to stop hypertension (DASH) diet on glucose variability in youth with Type 1 diabetes. Diabetes Manag (Lond) 2017; 7: 383-391
• 58 Ahola AJ, Freese R, Mäkimattila S. et al. Dietary patterns are associated with various vascular health markers and complications in type 1 diabetes. J Diabetes Complicat 2016; 30: 1144-1150
• 59 Ahola AJ, Gordin D, Forsblom C. et al. Association between diet and measures of arterial stiffness in type 1 diabetes – Focus on dietary patterns and macronutrient substitutions. Nutr Metab Cardiovasc Dis 2018; 28: 1166-1172
• 60 Jaacks LM, Crandell J, Mendez MA. et al. Dietary patterns associated with HbA_1c and LDL cholesterol among individuals with type 1 diabetes in China. J Diabetes Complicat 2015; 29: 343-349
• 61 Lamichhane AP, Liese AD, Urbina EM. et al. Associations of dietary intake patterns identified using reduced rank regression with markers of arterial stiffness among youth with type 1 diabetes. Eur J Clin Nutr 2014; 68: 1327-1333
• 62 van Bussel BCT, Soedamah-Muthu SS, Henry RMA. et al. Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: the EURODIAB study. Nutr Metab Cardiovasc Dis 2013; 23: 758-764
• 63 Ahola AJ, Forsblom C, Groop PH. Adherence to special diets and its association with meeting the nutrient recommendations in individuals with type 1 diabetes. Acta Diabetol 2018; 55: 843-851
• 64 Scarpello JH. Treatment of a diabetic vegetarian with human insulin (recombinant DNA): a case report. Diabetes Care 1982; 5 (Suppl. 02) 180
• 65 Rudkin CL. Vegetarian diet planning for adolescents with diabetes. Pediatr Nurs 1999; 25: 262-266
• 66 Tromba V, Silvestri F. Vegetarianism and type 1 diabetes in children. Metabol Open 2021; 11: 100099
• 67 Agnoli C, Baroni L, Bertini I. et al. Position paper on vegetarian diets from the working group of the Italian Society of Human Nutrition. Nutr Metab Cardiovasc Dis 2017; 27: 1037-1052
• 68 Barberi S, Bergamini M, Banani RB. et al. Position paper: Diete vegetariane in gravidanza ed in età evolutiva. Pediatria Preventiva & Sociale 2017; 12 (Suppl. 03) 1-77
• 69 Kontessis PA, Bossinakou I, Sarika L. et al. Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients. Diabetes Care 1995; 18: 1233
• 70 Jibani MM, Bloodworth LL, Foden E. et al. Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: effects on albumin excretion rate and nutritional status. Diabet Med 1991; 8: 949-953
• 71 Kahleova H, Znayenko-Miller T, Jayaraman A. et al. Vegan diet, processed foods, and body weight: a secondary analysis of a randomized clinical trial. Nutr Metab (Lond) 2025; 22: 21
• 72 Kahleova H, Fischer I, Smith R. et al. Plant-based dietary index and body weight in people with type 1 diabetes: a secondary analysis of a randomized clinical trial. Front Nutr 2025; 12: 1605769
• 73 Zuromski KL, Witte TK, Smith AR. et al. Increased prevalence of vegetarianism among women with eating pathology. Eat Behav 2015; 19: 24-27
• 74 Siepmann T, Roofeh J, Kiefer FW. et al. Hypogonadism and erectile dysfunction associated with soy product consumption. Nutrition 2011; 27: 859-862
• 75 Gill S, Panda S. A Smartphone App Reveals Erratic Diurnal Eating Patterns in Humans that Can Be Modulated for Health Benefits. Cell Metab 2015; 22: 789-798
• 76 Kahleova H, Lloren JI, Mashchak A. et al. Meal Frequency and Timing Are Associated with Changes in Body Mass Index in Adventist Health Study 2. J Nutr 2017; 147: 1722-1728
• 77 McCrory MA, Howarth NC, Roberts SB. et al. Eating frequency and energy regulation in free-living adults consuming self-selected diets. J Nutr 2011; 141: 148-153
• 78 Ohkawara K, Cornier MA, Kohrt WM. et al. Effects of increased meal frequency on fat oxidation and perceived hunger. Obesity (Silver Spring) 2013; 21: 336-343
• 79 Kahleova H, Belinova L, Malinska H. et al. Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reducedenergy regimen for patients with type 2 diabetes: a randomised crossover study. Diabetologia 2014; 57: 1552-1560
• 80 Koopman KE, Caan MWA, Nederveen AJ. et al. Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: a randomized controlled trial. Hepatology 2014; 60: 545-553
• 81 St-Onge MP, Ard J, Baskin ML. et al. Meal Timing and Frequency: Implications for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association. Circulation 2017; 135: e96-e121
• 82 Stote KS, Baer DJ, Spears K. et al. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middleaged adults. Am J Clin Nutr 2007; 85: 981-988
• 83 Tinsley GM, Forsse JS, Butler NK. et al. Time-restricted feeding in young men performing resistance training: A randomized controlled trial. Eur J Sport Sci 2017; 17: 200-207
• 84 Moro T, Tinsley G, Bianco A. et al. Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistancetrained males. J Transl Med 2016; 14: 290
• 85 Nas A, Mirza N, Hägele F. et al. Impact of breakfast skipping compared with dinner skipping on regulation of energy balance and metabolic risk. Am J Clin Nutr 2017; 105: 1351-1361
• 86 Sutton EF, Beyl R, Early KS. et al. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes. Cell Metab 2018; 27: 1212-1221.e3
• 87 Ravussin E, Beyl RA, Poggiogalle E. et al. Early Time-Restricted Feeding Reduces Appetite and Increases Fat Oxidation But Does Not Affect Energy Expenditure in Humans. Obesity (Silver Spring) 2019; 27: 1244-1254
• 88 Mattson MP, Allison DB, Fontana L. et al. Meal frequency and timing in health and disease. Proc Natl Acad Sci U S A 2014; 111: 16647-16653
• 89 Bo S, Fadda M, Castiglione A. et al. Is the timing of caloric intake associated with variation in diet-induced thermogenesis and in the metabolic pattern? A randomized cross-over study. Int J Obes (Lond) 2015; 39: 1689-1695
• 90 Henry CJ, Kaur B, Quek RYC. Chrononutrition in the management of diabetes. Nutr Diabetes 2020; 10: 6
• 91 Wilkinson MJ, Manoogian ENC, Zadourian A. et al. Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. Cell Metab 2020; 31: 92-104.e5
• 92 Trepanowski JF, Kroeger CM, Barnosky A. et al. Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial. JAMA Intern Med 2017; 177: 930-938
• 93 Sundfør TM, Svendsen M, Tonstad S. Effect of intermittent versus continuous energy restriction on weight loss, maintenance and cardiometabolic risk: A randomized 1-year trial. Nutr Metab Cardiovasc Dis 2018; 28: 698-706
• 94 Schübel R, Nattenmüller J, Sookthai D. et al. Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial. Am J Clin Nutr 2018; 108: 933-945
• 95 Carter S, Clifton PM, Keogh JB. Effect of Intermittent Compared With Continuous Energy Restricted Diet on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Noninferiority Trial. JAMA Netw Open 2018; 1: e180756
• 96 Corley BT, Carroll RW, Hall RM. et al. Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabet Med 2018; 35: 588-594
• 97 Horne BD, Grajower MM, Anderson JL. Limited Evidence for the Health Effects and Safety of Intermittent Fasting Among Patients With Type 2 Diabetes. JAMA 2020; 324: 341-342
• 98 Fortin A, Rabasa-Lhoret R, Lemieux S. et al. Comparison of a Mediterranean to a low-fat diet intervention in adults with type 1 diabetes and metabolic syndrome: A 6-month randomized trial. Nutr Metab Cardiovasc Dis 2018; 28: 1275-1284
• 99 Lawrence JM, Liese AD, Liu L. et al. Weight-loss practices and weightrelated issues among youth with type 1 or type 2 diabetes. Diabetes Care 2008; 31: 2251-2257
• 100 Rosenfalck AM, Almdal T, Viggers L. et al. A low-fat diet improves peripheral insulin sensitivity in patients with Type 1 diabetes. Diabet Med 2006; 23: 384-392
• 101 Nielsen JV, Jönsson E, Ivarsson A. A low carbohydrate diet in type 1 diabetes: clinical experience – a brief report. Ups J Med Sci 2005; 110: 267-273
• 102 Burge MR, Castillo KR, Schade DS. Meal composition is a determinant of lispro-induced hypoglycemia in IDDM. Diabetes Care 1997; 20: 152-155
• 103 Ranjan A, Schmidt S, Damm-Frydenberg C. et al. Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open-label crossover trial. Diabetes Obes Metab 2017; 19: 1479-1484
• 104 Ranjan A, Schmidt S, Damm-Frydenberg C. et al. Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study. Diabetes Care 2017; 40: 132-135
• 105 Rabasa-Lhoret R, Garon J, Langelier H. et al. Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen. Diabetes Care 1999; 22: 667-673
• 106 Anderson JW, Zeigler JA, Deakins DA. et al. Metabolic effects of highcarbohydrate, high-fiber diets for insulin-dependent diabetic individuals. Am J Clin Nutr 1991; 54: 936-943
• 107 McKewen MW, Rehrer NJ, Cox C. et al. Glycaemic control, muscle glycogen and exercise performance in IDDM athletes on diets of varying carbohydrate content. Int J Sports Med 1999; 20: 349-353
• 108 Thinggaard M, Jacobsen R, Jeune B. et al. Is the relationship between BMI and mortality increasingly U-shaped with advancing age? A 10- year follow-up of persons aged 70–95 years. J Gerontol A Biol Sci Med Sci 2010; 65: 526-531
• 109 Guigoz Y, Vellas BJ. Malnutrition im Alter: Das Mini Nutritional Assessment (MNA). Ther Umsch 1997; 54: 345-350
• 110 Rubenstein LZ, Harker JO, Salvà A. et al. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci 2001; 56: M366-M372
• 111 Tetzschner R, Nørgaard K, Ranjan A. Effects of alcohol on plasma glucose and prevention of alcohol-induced hypoglycemia in type 1 diabetes – A systematic review with GRADE. Diabetes Metab Res Rev 2018; 34: e2965
• 112 Liu X, Zhang Y, Wu H. et al. Intake of polyunsaturated fatty acids and risk of preclinical and clinical type 1 diabetes in children-a systematic review and meta-analysis. Eur J Clin Nutr 2019; 73: 1-8
• 113 Cadario F, Pozzi E, Rizzollo S. et al. Vitamin D and ω-3 Supplementations in Mediterranean Diet During the 1st Year of Overt Type 1 Diabetes: A Cohort Study. Nutrients 2019; 11: 2158
• 114 Antonucci R, Locci C, Clemente MG. et al. Vitamin D deficiency in childhood: old lessons and current challenges. J Pediatr Endocrinol Metab 2018; 31: 247-260
• 115 Rak K, Bronkowska M. Immunomodulatory Effect of Vitamin D and Its Potential Role in the Prevention and Treatment of Type 1 Diabetes Mellitus-A Narrative Review. Molecules 2018; 24: 53
• 116 Dong JY, Zhang WG, Chen JJ. et al. Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients 2013; 5: 3551-3562
• 117 Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review andmeta-analysis. Arch Dis Child 2008; 93: 512-517
• 118 Altieri B, Muscogiuri G, Barrea L. et al. Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept. Rev Endocr Metab Disord 2017; 18: 335-346
• 119 Gregoriou E, Mamais I, Tzanetakou I. et al. The Effects of Vitamin D Supplementation in Newly Diagnosed Type 1 Diabetes Patients: Systematic Review of Randomized Controlled Trials. Rev Diabet Stud 2017; 14: 260-268
• 120 Thorsen SU, Halldorsson TI, Bjerregaard AA. et al. Maternal and Early Life Iron Intake and Risk of Childhood Type 1 Diabetes: A Danish Case-Cohort Study. Nutrients 2019; 11: 734
• 121 Lin CC, Huang YL. Chromium, zinc and magnesium status in type 1 diabetes. Curr Opin Clin Nutr Metab Care 2015; 18: 588-592
• 122 Jayawardena R, Ranasinghe P, Galappatthy P. et al. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr 2012; 4: 13
• 123 Chimienti F. Zinc, pancreatic islet cell function and diabetes: new insights into an old story. Nutr Res Rev 2013; 26: 1-11
• 124 Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res 2020; 30: 492-506
• 125 Arpaia N, Campbell C, Fan X. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504: 451-455
• 126 Smith PM, Howitt MR, Panikov N. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569-573
• 127 Bosi E, Molteni L, Radaelli MG. et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 2006; 49: 2824-2827
• 128 Brown CT, Davis-Richardson AG, Giongo A. et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 2011; 6: e25792
• 129 de Goffau MC, Luopajärvi K, Knip M. et al. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 2013; 62: 1238-1244
• 130 Kostic AD, Gevers D, Siljander H. et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 2015; 17: 260-273
• 131 Davis-Richardson AG, Ardissone AN, Dias R. et al. Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front Microbiol 2014; 5: 678
• 132 de Goffau MC, Fuentes S, van den Bogert B. et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 2014; 57: 1569-1577
• 133 Alkanani AK, Hara N, Gottlieb PA. et al. Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes. Diabetes 2015; 64: 3510-3520
• 134 Vatanen T, Franzosa EA, Schwager R. et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 2018; 562: 589-594
• 135 Vatanen T, Kostic AD, dʼHennezel E. et al. Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans. Cell 2016; 165: 842-853
• 136 Uusitalo U, Liu X, Yang J. et al. Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study. JAMA Pediatr 2016; 170: 20-28
• 137 Savilahti E, Härkönen T, Savilahti EM. et al. Probiotic intervention in infancy is not associated with development of beta cell autoimmunity and type 1 diabetes. Diabetologia 2018; 61: 2668-2670
• 138 Zare Javid A, Aminzadeh M, Haghighi-Zadeh MH. et al. The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial. Diabetes Metab Syndr Obes 2020; 13: 607-617
• 139 Zheng M, Zhang R, Tian X. et al. Assessing the Risk of Probiotic Dietary Supplements in the Context of Antibiotic Resistance. Front Microbiol 2017; 8: 908
• 140 Wong A, Ngu DYS, Dan LA. et al. Detection of antibiotic resistance in probiotics of dietary supplements. Nutr J 2015; 14: 95
• 141 Singhi SC, Kumar S. Probiotics in critically ill children. F1000Res 2016; 5: 407